Walvax Will Spend $112 Million to Up Vaccine Capacity
Published: Jun 29, 2011
June 29, 2011 -- Walvax Biotechnology has received board approval for a 727 million RMB ($112 million) building project. The money will be used to finance construction of the third phase of the company’s production facility in Yunnan province. Walvax, a vaccine manufacturer, completed a very successful IPO on the ChiNext exchange in November 2010, raising $358 million. More details....
Stock Symbol: (SHE: 300142)